Szemészet, 2012 (149. évfolyam, 1-4. szám)

2012-09-01 / 3. szám

Ocular and systemic associations of pseudoexfoliation syndrome - A CMO review

19. Romero-Aroca R Masip-Serra R, Martínez-Salcedo I, et a I. A high prevalence of pseudoexfoilation syndrome and its complications in Tarragona in northeast Spain. Eur J Ophthalmol 2011; 21: 580-588.

20. Walinder PE, Olivius EO, Nordell SI, Thorburn WE. Fibrinoid reaction after extracapsular katarakt extraction and relationship to exfoliation syndrome. J Caratact Refract Surg 1989; 15: 526-530.

21. Holló G, Kóthy R Konstas AGP Association of Cogan-Reese syndrome, exfoliation syndrome and secondary open-angle glaucoma. Case report. Eur J Ophthalmol 2012; 22:120-123.

22. Konstas AGR Holló G, Astakhov YS, et a I. Factors Associated with Long-term Progression or Stability in Exfoliation Glaucoma. Arch Ophthalmol 2004; 122: 29-33.

23. Konstas AGR Holló G, Astakhov YS, et al. Presentation and long-term follow-up of exfoliation glaucoma in Greece, Spain, Russia and Hungary. Eur J Ophthalmol 2006; 16: 60-66.

24. Konstas AGP Holló G, Irkec M, et al. Diurnal IOP control with bimatoprost vs latanoprost in exfoliative glaucoma: A crossover observer-masked three-center study. Br J Ophthalmol 2007; 91: 757-760.

25. Konstas AGR Holló G, Mikropoulos D, et al. Twenty-four hour intraocular pressure control with bimatoprost and the bimatoprost/ timolol fixed combination administered in the morning, or evening in exfoliative glaucoma. Br J Ophthalmol 2010; 94: 209-213.

26. Konstas AGR Mikropoulos DG, Embeslidis TA, et al. 24-hour intraocular pressure control with evening-dosed travoprost/timolol compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma. Eye 2010; 24: 1606-1613.

27. Holló G, Vargha R Follmann R Süveges I. Az argon lézer trabeculoplasties szerepe a pseudoexfoilativ glaucoma kezelésében. Szemészet 1996; 133: 211-216.

28. Merkur A, Damji KE Minstsioulis G, Hodge WG. Intraocular pressure decrease after phacoemulsification in patients with pseudoexfoilation syndrome. J Katarakt Refract Surg 2001; 27: 528-532.

29. Heilj A, Bengtsson B, Hyman L, Leske C, for the Early Manifest Glaucoma Trial Group. Natural history of open-angle glaucoma: Ophthalmology 2009; 116: 2271-2276.

30. Holló G, Kerényi Á, Kékedi R, Sziklai R Milibák T: A glaucomaellenes filtrációs műtét indikálása Magyarországon 2011-ben: túl későn cselekszünk. Szemészet 2011;148:117-122.

31. Mitchell R Wang JJ, Smith W. Association of pseudoexfoilation syndrome with increased vascular risk. Am J Ophthalmol 1997; 124: 685-687.

32. Ritland JS, Egge К, Lydersen S, et al. Exfoliative glaucoma and primary

open-angle glaucoma: associations with death causes and comorbidity. Acta Ophthalmol 2004; 82: 401-404.

33. Shrum KR, Hattenhauer MG, Hodge D. Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoilation. Am J Ophthalmol 2000; 129: 83-86.

34. Ringvold A, Blika S, Sandvik L. Pseudo-exfoliation and mortality. Acta Ophthalmol 1997; 75: 255-256.

35. Topouzis E Wilson MR, Harris A, et al. Risk factors for primary openangle glaucoma and pseudoexfoilative glaucoma in the Thessaloniki Eye Study. Am J Ophthalmol 2011; 152: 219-228.

36. Holló G, Cvenkel B, Teus MA, et al. Is there any difference in target intraocular pressure for exfoliative glaucoma patients with and without cardiovascular disease history? Eur J Ophthalmol 2010; 20: 1000-1006.

37. Holló G, Józsa G, Kempler R et al. A szisztémás vérkeringés szabályozásának változása capsularis glaukómában. Szemészet 1998; 135: 51-54.

38. Holló G, Lakatos R Farkas K. Cold pressor test and plasma endothelin- 1 concentration in primary open-angle and capsular glaucoma. J Glaucoma 1998; 7: 105-110.

39. Visontai Zs, Merisch B, Kollai M, Holló G. Increase of carotid artery stiffness and decrease of baroreflex sensitivity in exfoliation syndrome and glaucoma. Br J Ophthalmol 2006; 90: 563-567.

40. Visontai Zs, Horváth T, Kollai M, Holló G. Decreased cardiovagal regulation in exfoliation syndrome. J Glaucoma 2008; 17:133-138.

41. Atalar PT, Atalar E, Kilic H, et al. Impaired systemic endothelial function in patients with pseudoexfoilation syndrome. Int Heart J 2006; 47: 77-84.

42. Praveen MR, Shah SK, Vasavada AR, et al. Pseudoexfoilation as a risk factor for peripheral vascular disease: a case-control study. Eye 2011; 25: 174-179.

43. Demir N, Ulus T, Yucel OE, et al. Assessment of myocardial ischaemia using tissue Doppler imaging in pseudoexfoilation syndrome. Eye 2011; 25: 1177-1180.

44. Holló G, Gál A, Kóthy R Molnár JM. LOXL1 gene sequence variants and vascular disease in exfoliation syndrome and exfoliative glaucoma. J Glaucoma 2011; 20: 143-147.

45. Yazdani S, Tousi A, Pakravan M, Faghihi A-R. Sensorineural hearing loss in pseudoexfoilation syndrome. Ophthalmology 2008; 115: 425-429.

46. Paliobei VR Psillas GK, Mikropoulos DG, et al. Hearing evaluation in patients with exfoliative and primary open-angle glaucoma. Otolaryngol Head Neck Surg 2011; 145: 125-130.

Levelezési cím

Holló Gábor; Semmelweis Egyetem, Szemészeti Klinika,

1083 Budapest, Tömő u. 25-29., E-mail: hg@szem1.sote.hu